Salbutamol with ipratropium bromide (Duolin HFA inhaler): Supply issue

Supply issue Active

Rex Medical has advised that, due to increased demand, there has been constrained supply of the Duolin HFA inhaler at supplier and wholesaler levels.

31 May 2023 update

Supply issue updated to indicate it is the Duolin inhaler that has the supply issue, not the Duolin nebuliser solution.

Affected product

  • Chemical: Salbutamol with ipratropium bromide 
  • Brand: Duolin HFA
  • Presentation: Inhaler
  • Pharmacode: 2349337

Expected resupply

Rex Medical is currently in discussion with Medsafe about releasing batches of inhalers. They hope to have a resolution by Friday 2 June 2023. This should mean that stock would be available for pharmacists from mid-June 2023.  

Pharmac is awaiting current stock-on-hand information from Rex Medical. We understand that a patient level disruption is unlikely.

Who to contact

If you have concerns regarding the supply of Duolin, contact Rex Medical: 0800 739 633

Sign up to our email list for regular emails about supply issues and more(external link)